Dedhia Nicket, Zamata-Ovalle Diego, Johnson Emma, Schwechter Evan
Department of Orthopaedic Surgery, Montefiore Medical Center, Bronx, NY.
Albert Einstein College of Medicine, Bronx, NY.
Arthroplast Today. 2024 Jul 3;28:101438. doi: 10.1016/j.artd.2024.101438. eCollection 2024 Aug.
Tenosynovial giant cell tumor (TGCT) occurs in both diffuse and localized forms. While diffuse TGCT is an uncommon but well-described complication after total knee arthroplasty (TKA), localized TGCT has only once been previously described as a postoperative complication after TKA. We report on the diagnosis and management of a patient who developed postoperative localized TGCT after routine TKA and underwent uncomplicated removal. Postoperatively the patient noted a resolution of pain and mechanical symptoms. Early consideration of this rare occurrence after TKA can prevent significant pain and disability due to delayed diagnosis.
腱鞘巨细胞瘤(TGCT)有弥漫性和局限性两种形式。虽然弥漫性TGCT是全膝关节置换术(TKA)后一种罕见但已得到充分描述的并发症,但局限性TGCT此前仅被描述过一次为TKA术后并发症。我们报告了一名患者的诊断和治疗情况,该患者在常规TKA术后发生了局限性TGCT,并顺利接受了切除手术。术后患者疼痛和机械性症状消失。对TKA术后这种罕见情况的早期考虑可以避免因诊断延迟而导致的严重疼痛和功能障碍。